Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV MR O'Donnell, A Daftary, M Frick, Y Hirsch-Moverman, KR Amico, ... The International Journal of Tuberculosis and Lung Disease 20 (4), 430-434, 2016 | 96 | 2016 |
Fighting TB stigma: we need to apply lessons learnt from HIV activism A Daftary, M Frick, N Venkatesan, M Pai BMJ global health 2 (4), e000515, 2017 | 78 | 2017 |
The TB vaccines pipeline: where are we going, where have we been M Frick Clayden P, Collins S, Daniels C, et al.; i-Base/Treatment Action Group, 2013 | 63* | 2013 |
2015 report on tuberculosis research funding trends, 2005–2014: a decade of data M Frick Treatment Action Group, 2015 | 54* | 2015 |
2016 report on tuberculosis research funding trends, 2005–2015: no time to lose M Frick Treatment Action Group, 2016 | 32 | 2016 |
Tuberculosis, human rights and ethics considerations along the route of a highly vulnerable migrant from sub-Saharan Africa to Europe V Wild, D Jaff, NS Shah, M Frick The International Journal of Tuberculosis and Lung Disease 21 (10), 1075-1085, 2017 | 28 | 2017 |
End stigmatizing language in tuberculosis research and practice M Frick, D von Delft, B Kumar Bmj 350, 2015 | 27 | 2015 |
The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities LR Mingote, D Namutamba, F Apina, N Barnabas, C Contreras, T Elnour, ... The Lancet 385 (9966), 477-479, 2015 | 25 | 2015 |
A community perspective on the inclusion of pregnant women in tuberculosis drug trials L McKenna, M Frick, C Lee, D Namutamba, L Smit, M Theunissen, ... Clinical Infectious Diseases 65 (8), 1383-1387, 2017 | 22 | 2017 |
The scientific response to TB–the other deadly global health emergency RE Chaisson, M Frick, P Nahid The International Journal of Tuberculosis and Lung Disease 26 (3), 186, 2022 | 20 | 2022 |
Public investments in the clinical development of bedaquiline D Gotham, L McKenna, M Frick, E Lessem PLoS One 15 (9), e0239118, 2020 | 20 | 2020 |
Funding for tuberculosis research—an urgent crisis of political will, human rights, and global solidarity M Frick International Journal of Infectious Diseases 56, 21-24, 2017 | 19 | 2017 |
Falling short of the rights to health and scientific progress: inadequate TB drug research and access M Frick, I Henry, E Lessem Health and human rights 18 (1), 9, 2016 | 19 | 2016 |
The evolving role of advocacy in tuberculosis A DeLuca, E Lessem, D Wegener, LR Mingote, M Frick, D Von Delft The Lancet Respiratory Medicine 2 (4), 258-259, 2014 | 18 | 2014 |
Tobacco retail clustering around schools in New York City: examining “place” and “space” M Frick, MC Castro Health & place 19, 15-24, 2013 | 18 | 2013 |
Activism on rifapentine pricing: removing cost barriers to improve the uptake of tuberculosis research innovations A DeLuca, M Frick, E Lessem, J Kanouse, D Wegener, LR Mingote Public health action 4 (4), 238-242, 2014 | 16 | 2014 |
Tuberculosis research and development: seeding the future C Lienhardt, A Zumla, N Gebreselassie, M Frick, G Gray, T Kasaeva, ... The Lancet Respiratory Medicine 6 (4), 242-244, 2018 | 14 | 2018 |
The tuberculosis vaccines pipeline: A new path to the same destination M Frick 2015 PIPELINE REPORT, 163, 2015 | 13 | 2015 |
The 1/4/6x24 campaign to cure tuberculosis quickly L McKenna, M Frick, K Angami, V Dubula, J Furin, M Harrington, ... Nature Medicine 29 (1), 16-17, 2023 | 12 | 2023 |
Fighting TB stigma: we need to apply lessons learnt from HIV activism. BMJ Glob Health. 2017; 2 (4): e000515 A Daftary, M Frick, N Venkatesan, M Pai Epub 2017/12/12. https://doi. org/10.1136/bmjgh-2017-000515 PMID: 29225954, 0 | 12 | |